
Andrew Dudum, founder and CEO of Hims, discusses the company's approach to healthcare innovation and disruption. Dudum argues that operating in the public market is more stimulating than being private due to the constant need to deliver results. He emphasizes hiring gritty individuals who thrive in chaos and prioritizing being the best in the market over being first. Hims operates as a "public shell for innovation," running multiple independent clinical categories as venture incubation units, allocating resources based on performance. Dudum also highlights the importance of brand marketing consistency and the company's commitment to affordable, accessible healthcare, even if it means disrupting traditional distribution models.
Sign in to continue reading, translating and more.
Continue